Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Employers who invest in evidence-based obesity treatment can improve recruitment and retention, support both physical and mental well-being, and demonstrate a genuine commitment to long-term employee well-being
Common symptoms include: Fatigue, drowsiness, and general weakness
Keeping a food diary can be helpful in correlating dietary habits with changes in your stools
For patients & payers: A step toward lower costs and broader access to proven obesity treatments For Teva Pharmaceuticals: A strategic move into one of the fastest-growing segments in global pharma For Novo Nordisk: Limited short-term impact, but mounting competitive pressure as generics gain ground This development could reshape affordability, accessibility, and competition in obesity care signaling the beginning of a new chapter for patients and healthcare systems worldwide
Pistoia, ND Mar 26, 2025 4 min read Updated: May 12 Ozempic has become a buzzword in weight loss and type 2 diabetes management
